Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | AKT1 | P31749 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9958346 | 0.86 | TP53 (0.42) | — | |
| Hydrochloric Acid SCHEMBL9958863 | 0.85 | TP53 (0.41) | — | |
| SCHEMBL10934217 | 0.80 | ALDH1A1 (0.44) | ALDH1A1TSHR | |
| SCHEMBL602525 | 0.75 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL12506346 | 0.75 | ELANE (0.46) | ALDH1A1 | |
| SCHEMBL12506348 | 0.75 | CCNA2 (0.30) | — | |
| SCHEMBL26404699 | 0.75 | ALDH1A1 (0.49) | ALDH1A1TSHR | |
| SCHEMBL10033092 | 0.74 | ALDH1A1 (0.47) | ALDH1A1TSHR | |
| SCHEMBL12506361 | 0.73 | MCL1 (0.34) | — | |
| SCHEMBL9959065 | 0.73 | ALDH1A1 (0.39) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8455657-B2 | Process for the preparation of 3-alkylsulfinylbenzoyl derivatives | BAYER CROPSCIENCE AG (DE) | 2013-06-04 | — | — | US | disclosed |
| US-20120165540-A1 | PROCESS FOR THE PREPARATION OF 3-ALKYLSULFINYLBENZOYL DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165540-A1 | PROCESS FOR THE PREPARATION OF 3-ALKYLSULFINYLBENZOYL DERIVATIVES | CBR3, CBR1, CYP1B1 | ALDH1A1 803/4885TSHR 1158/4885TRPA1 2833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.